Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
European Journal of Cancer
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
  • Articles
    • Cover Image - European Journal of Cancer, Volume 187, Issue
    • Latest

      • Articles in Press
      • Issues in Progress
      • Current Issue
      • Past Issues
      • Special Issues
    • Popular Articles

      • Original Research
        Open Access

        Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

          Hertler et al.
      • Original Research
        Open Access

        Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study

          Saito et al.
      • Original Research
        Open Access

        Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer

          Geukens et al.
    • Latest Articles

      • Letter to the Editor

        Cancer in conflict: The impact of the war in Ukraine on Moldova

        • Horia Vulpe
        • Artiom Minzatean
        • Stefania Magidson
        • Irena Tocino
        • Rodica Mindruta-Stratan
        • Lars Johan Lönnback
        • Ursula Wagner
        • Violina Nazaria
        • Eugenia Ciubotaru
        • Nicoleta Minzatean
        • Veronica Ciobanu
        • Sergiu Brenister
        • Ludmila Circiumari
        • Cristian Teglas
        • Richard Sullivan
        • Ruslan Baltaga
      • Current Perspective

        The emerging promise of tumor mechanobiology in cancer treatment

          Papavassiliou et al.
      • Letter to the Editor

        Long-lasting CRs after ibrutinib monotherapy for relapse or refractory primary CNS lymphoma (PCNSL) and primary vitreoretinal lymphoma (PVRL): Long-term results of the iLOC study by the Lymphoma Study Association (LYSA) and the French Oculo-Cerebral Lymphoma (LOC) Network (clinical trial number: NCT02542514)

        • Carole Soussain
        • Denis Malaise
        • Sylvain Choquet
        • Hervé Ghesquières
        • Caroline Houillier
  • Publish
    • For Authors

      • Submit Article
        External Link
      • Guide for Authors
      • Aims & Scope
      • Open Access Information
        External Link
      • Researcher Academy
        External Link
      • EJC Author Form
  • Multimedia
      • Podcasts
  • About
    • Society

      • Society Information
      • Editorial Board
      • EORTC
        External Link
      • EUSOMA
        External Link
    • Journal Information

      • Aims & Scope
      • Abstracting & Indexing
      • PracticeUpdate
        External Link
    • Access

      • Subscribe
      • Activate Online Access
  • Contact
    • Contact

      • Contact Us
      • Advertise with Us
        External Link
      • Go to Product Catalog
        External Link
    • Follow Us

      • New Content Alerts
      • Twitter
        External Link
Advanced search
Advanced search

Please enter a term before submitting your search.

Ok

You have requested a feature that requires you to Log In

Show
Forgot password?
Don’t have an account?
Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel

You have requested a feature that requires you to Log In

Show
Forgot password?
Don’t have an account?
Create a Free Account
  • Home
  • Articles & Issues
  • Articles in Press
  • Current Issue
  • Past Issues
  • EJC Supplements
  • Collections
  • Special Issues
  • Authors
  • About Open Access
  • Author Information
  • EJC Author Form
  • Researcher Academy
  • Submit Manuscript
  • Journal
  • About Open Access
  • About the Journal
  • Abstracting/Indexing
  • Activate Online Access
  • Contact Information
  • Editorial Board
  • Info for Advertisers
  • Pricing
  • Sign up for e-Alerts
  • Subscribe
  • Societies
  • EORTC
  • EUSOMA
  • Society Information
  • PracticeUpdate
  • More Periodicals
  • Find a Periodical
  • Go to Product Catalog
  • Follow Us
  • Twitter
  • RSS Feed

The content on this site is intended for healthcare professionals.



We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

  • Privacy Policy  
  • Terms and Conditions  
  • Accessibility  
  • Help & Contact

RELX